Result Summary for 208140/032
| Protocol ID: | 208140/032 |
| Clinical Study ID: | 208140/032 |
| Official Title: | Open clinical study of the immunogenicity and reactogenicity of SB Biologicals’ DTPa-HBV vaccine, when coadministered with SB Biologicals’ Hib vaccine in 2 concomitant injections into opposite limbs, as a primary vaccination course in healthy infants aged 2, 4 and 6 months, followed by a booster at 18 months |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Haemophilus influenzae Type b Vaccine |
| Trade/Product Name: | Hiberix;Hiberix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
